Chronic cough, defined as a cough persisting beyond eight weeks, presents a diagnostic challenge to clinicians due to its multi-factorial etiology. It can significantly impair quality of life, causing physical, social, and psychological distress. This article provides a comprehensive approach to diagnosing and managing chronic cough in clinical practice.
The initial evaluation of a patient with chronic cough should include a detailed history and physical examination to identify common causes such as gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). Diagnostic tests should be guided by the patient's history and physical examination. In cases where common causes are ruled out, more extensive testing may be required to identify less common causes such as non-asthmatic eosinophilic bronchitis, bronchiectasis, or neoplasms.
Treatment should primarily target the underlying cause of the cough. For example, proton pump inhibitors may be prescribed for GERD, inhaled corticosteroids for asthma, and antihistamines for UACS. If the cough persists despite treatment, it may be classified as a refractory chronic cough. In these cases, a multidisciplinary approach involving pulmonologists, gastroenterologists, and otolaryngologists may be beneficial. Non-pharmacological interventions such as speech and language therapy can also be considered.
Recent research has highlighted the role of neuronal hypersensitivity in the pathogenesis of chronic cough. New therapies targeting neuronal pathways such as P2X3 receptor antagonists and transient receptor potential (TRP) channel modulators are currently under investigation and may offer new hope for patients with refractory chronic cough.
In conclusion, chronic cough is a complex medical condition that requires a thorough diagnostic evaluation and a targeted treatment approach. The management of refractory cases can be challenging, but emerging therapies offer promising avenues for future treatment. Continued research and collaboration across specialties are essential for advancing our understanding and management of this debilitating condition.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation